+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
From
Protiofate (CAS 58416-00-5) Global Market Research Report 2024 - Product Thumbnail Image

Protiofate (CAS 58416-00-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Propiverine (CAS 60569-19-9) Global Market Research Report 2024 - Product Thumbnail Image

Propiverine (CAS 60569-19-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Ramosetron (CAS 132036-88-5) Global Market Research Report 2024 - Product Thumbnail Image

Ramosetron (CAS 132036-88-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Simethicone (CAS 8050-81-5) Global Market Research Report 2024 - Product Thumbnail Image

Simethicone (CAS 8050-81-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Roxatidine (CAS 78273-80-0) Global Market Research Report 2024 - Product Thumbnail Image

Roxatidine (CAS 78273-80-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Rabeprazole (CAS 117976-89-3) Global Market Research Report 2024 - Product Thumbnail Image

Rabeprazole (CAS 117976-89-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
Piperidolate (CAS 82-98-4) Global Market Research Report 2024 - Product Thumbnail Image

Piperidolate (CAS 82-98-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more